Piper plays down significance of Tesla Autopilot case in Florida
FRANKLIN, Tenn. - Acadia Healthcare Company, Inc. (NASDAQ:ACHC) reported fourth quarter earnings that fell short of analyst expectations, while also issuing disappointing guidance for 2025, sending shares tumbling over 12% in after-hours trading.
The behavioral health services provider posted adjusted earnings per share of $0.64 for Q4, missing the consensus estimate of $0.72. Revenue came in at $774.2 million, up 4.2% YoY but below analysts’ projections of $780.22 million.
For the full year 2025, Acadia forecast earnings per share between $2.50 and $2.80, well below Wall Street’s expectation of $3.36. The company guided for 2025 revenue of $3.3 billion to $3.4 billion, also short of the $3.43 billion consensus.
"Our fourth quarter financial and operating results capped off a year of solid growth and progress for Acadia," said CEO Chris Hunter. "The continued momentum in our business allowed us to achieve record annual revenue of $3.2 billion."
Same facility revenue increased 4.7% in Q4 compared to the prior year period, driven by a 3.2% rise in patient days and a 1.4% increase in revenue per patient day.
Acadia added 577 newly licensed beds during the quarter, including 233 beds to existing facilities and 344 licensed beds from newly constructed facilities. The company completed construction on approximately 1,100 beds in Q4, bringing its full year total to about 1,300 newly constructed beds.
For Q1 2025, Acadia expects revenue between $765 million and $775 million, significantly below analysts’ estimates of $822 million.
The company’s board also authorized a new $300 million share repurchase program.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.